News|Videos|December 9, 2015
Using Platelet Aggregation Inhibitors in Different Patient Populations
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the different nuances pharmacists have to consider when using platelet aggregation inhibitors in different patient populations.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the different nuances pharmacists have to consider when using platelet aggregation inhibitors in different patient populations.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
Evaluating Pharmacists’ Role In Veterinary Medication Management and Education
4
Psychiatric Disorders Have Increased in More Recent Birth Cohorts, Study Suggests
5